The Aerobic Exercise Capacity and Muscle Strenght in Individuals With COVID-19
Conditions: COVID-19 Pneumonia; COVID-19 Interventions: Device: Kardiopulmonary exercise test (Quark KPET C12x/T12x device connected to the Omnia version 1.6.8 COSMED system); Device: Peripheral muscle strength measurement (microFET3 (Hoggan Health Industries, Fabrication Enterprises, lnc) and JAMAR hydraulic hand dynamometer (Sammons Preston, Rolyon, Bolingbrook).; Device: Standard exercise tolerance test (a bicycle ergometer and recorded through the ergoline rehabilitation system 2 Version 1.08 SPI.); Device: Aerobic exercise training (a bicycle ergometer and recorded through the ergoline rehabilitation system 2 Version ...
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
Conditions: COVID-19 Pandemic; COVID-19 Vaccines Interventions: Biological: INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg Sponsors: Dr. Soetomo General Hospital; Indonesia-MoH; Universitas Airlangga; PT Biotis Pharmaceuticals, Indonesia Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Treatment of Post-COVID With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
Conditions: Post-COVID-19 Syndrome; Post-COVID Syndrome; Post COVID-19 Condition; Post-COVID Condition; Post COVID-19 Condition, Unspecified; Long COVID; Long Covid19 Interventions: Drug: Hyperbaric oxygen Sponsors: Erasmus Medical Center; Da Vinci Clinic; HGC Rijswijk Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt
Conditions: Mucormycosis; Rhinocerebral (Etiology); COVID-19 Interventions: Procedure: debridment Sponsors: Nasser Institute For Research and Treatment Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Mindfulness-based Mobile Applications Program
Conditions: COVID-19; Cell Phone Use; Nurse; Mental Health Interventions: Device: mindfulness-based mobile applications program Sponsors: Yu-Chien Huang Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Attention Training for COVID-19 Related Distress
Conditions: Anxiety Interventions: Behavioral: Attention Bias Modification; Behavioral: Attention Control Training; Behavioral: Neutral training Sponsors: Palo Alto University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
Conditions: Post-COVID-19 Syndrome; Post-COVID Syndrome; Post COVID-19 Condition; Post-COVID Condition; Post COVID-19 Condition, Unspecified; Long COVID; Long Covid19 Interventions: Drug: Hyperbaric oxygen Sponsors: Erasmus Medical Center; Da Vinci Clinic; HGC Rijswijk Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Patient Enrollment Completed for Opvika Phase I/II Clinical Trial in the U.S
WUHAN, China and SAN DIEGO, Feb. 19, 2024. Neurophth Therapeutics, Inc. ( " Neurophth " ) announced today that the last patient has been enrolled in Phase I/II clinical trial of Opvika (Esonadogene Imvoparvovec) for the treatment of Leber hereditary... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 19, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
Conditions: Advanced Pancreatic Adenocarcinoma Interventions: Drug: Y101D Sponsors: Wuhan YZY Biopharma Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Conditions: Malignant Ascites Interventions: Drug: M701; Drug: paracentesis Sponsors: Wuhan YZY Biopharma Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Tirofiban After Successful MT Recanalization in AIS
Conditions: Acute Ischemic Stroke; Vessel Occlusion Interventions: Drug: Tirofiban; Drug: Saline placebo Sponsors: Xiang Luo; Wuhan Central Hospital; Wuhan University; Renmin Hospital of Wuhan University; Second Affiliated Hospital of Soochow University; The First Affiliated Hospital of Zhengzhou University; Wuhan Hospital of Traditional Chinese Medicine; The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture; Huangshi Central Hospital, China; The First Affiliated Hospital of Yangtze University; The Fifth Hospital of Wuhan; Wuhan Puren Hospital; Xiangyang No.1 People ' s Hospital; Xianning Central Hospital; Wuh...
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)
Conditions: COVID-19 Pandemic; COVID-19 Vaccines; COVID-19 Virus Disease Interventions: Biological: INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg Sponsors: Dr. Soetomo General Hospital; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia; Indonesia-MoH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.
Conditions: Covid-19 Interventions: Diagnostic Test: COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Sponsors: Vachira Phuket Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Adjuvant treatment to reduce cardiovascular risk in patients with long covid: high-definition transcranial direct current stimulation (hd-tdcs) and chlorella pyreinoidosa
Conditions: Cardiovascular Diseases; Long Covid19 Interventions: Other: High Definition-transcranial Direct Current Stimulation; Dietary Supplement: Chlorella Pyreinodosa Sponsors: Federal University of Para íba; City University of New York Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.
Conditions: COVID-19 Interventions: Drug: CD40.RBDv vaccin (SARS-Cov2 Vaccin) Sponsors: ANRS, Emerging Infectious Diseases; LinKinVax; Vaccine Research Institute (VRI), France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
